Isleworth Healthcare Acquisition Corporation (ISLE)

Business: Isleworth Healthcare Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

IPO Date: 29-Mar-2021

CEO & Director: Mr. Robert S. Whitehead

CFO, Exec. VP & Director: Mr. Danny Lynn Halvorson

Listing: NASDAQ: ISLE

Country: United States

Headquarters: Saint Petersburg, FL

Website: https://isleworthhealthcare.com

Market cap: $260.34 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $4.15 Mln

Cash: $0.52 Mln

Total Debt: $0.00 Mln

Insider's Holding: 19.76%

Liquidity: Low

52 Week range: $9.67 - 9.95

Shares outstanding: 26,191,200

9 Years Aggregate:

• CFO: $346.39 Mln
• EBITDA: $400.26 Mln
• Net Profit: $-71.46 Mln